hERG Screening

A Global Strategic Business Report

MCP33920

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

6951

EXECUTIVE POOL

5850

PRICE

812

EXPERT INPUTS

33

COMPANIES

300

DATA TABLES

363

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global hERG Screening Market to Reach US$4.9 Billion by 2030

The global market for hERG Screening estimated at US$2.4 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2024-2030. Gene KCNH2 Type, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Mutant KCNH2 Type segment is estimated at 9.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$654.8 Million While China is Forecast to Grow at 17.3% CAGR

The hERG Screening market in the U.S. is estimated at US$654.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 17.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.1% and 11.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.1% CAGR.

Global hERG Screening Market – Key Trends & Drivers Summarized

Why Is hERG Screening Critical in Modern Drug Development Pipelines?

hERG (human Ether-à-go-go-Related Gene) screening is a crucial safety assay in drug discovery, used to evaluate a compound’s potential to block the cardiac potassium ion channel encoded by the KCNH2 gene. Inhibition of this channel can lead to QT interval prolongation and increase the risk of life-threatening cardiac arrhythmias such as Torsades de Pointes. As such, hERG screening has become a mandated component of preclinical safety pharmacology by global regulatory agencies including the FDA, EMA, and ICH.

Due to its implications for cardiac safety, hERG screening is essential not only for cardiovascular drugs but also for therapeutics across oncology, CNS, and infectious diseases. Drug candidates that show potential cardiotoxicity are typically modified, deprioritized, or withdrawn early in the pipeline, saving companies millions in downstream costs. This screening is also vital in lead optimization, enabling medicinal chemists to de-risk and refine compounds before entering animal or human studies.

How Are Technologies Advancing the Accuracy and Throughput of hERG Assays?

Recent advances in high-throughput screening (HTS), patch-clamp electrophysiology, and predictive computational modeling have significantly enhanced the precision and scalability of hERG testing. Automated planar patch-clamp platforms such as QPatch and SyncroPatch allow for high-content screening of ion channel activity with reduced labor and time investment. Similarly, fluorescence-based assays and voltage-sensitive dyes provide cost-effective alternatives for early-stage compound profiling.

In silico modeling and machine learning are now being applied to predict hERG liability based on chemical structure, reducing the need for exhaustive in vitro testing. The use of human iPSC-derived cardiomyocytes as a physiologically relevant platform for hERG evaluation is also gaining traction, especially under the Comprehensive In Vitro Proarrhythmia Assay (CiPA) initiative. These technologies are improving predictability and regulatory alignment in preclinical cardiotoxicity assessment.

Which Sectors and Regions Are Leading hERG Screening Demand?

Pharmaceutical and biotechnology companies represent the primary end-users of hERG screening, integrating these assays during early preclinical development and regulatory submission phases. CROs (Contract Research Organizations) are also major providers of hERG screening services, offering scalable, outsourced assay capabilities to drug developers. Academic institutions and toxicology research labs utilize hERG models for cardiac safety evaluation and channelopathy research.

Geographically, North America dominates the hERG screening market, driven by intensive drug development activity, stringent regulatory requirements, and advanced laboratory infrastructure. Europe follows, with a strong focus on regulatory science and public-private drug development collaborations. Asia-Pacific is emerging as a high-growth region, especially China and India, where pharmaceutical R&D spending is rising and global drugmakers are outsourcing early toxicology studies.

The Growth in the hERG Screening Market Is Driven by Several Factors…

The growth in the hERG screening market is driven by several factors related to safety pharmacology mandates, drug development complexity, and technology-driven screening innovation. Advances in automated patch-clamp systems, human-relevant cell models, and predictive AI-based screening tools have significantly enhanced throughput, accuracy, and regulatory compliance. These innovations are reducing time-to-decision for drug safety profiling while minimizing clinical failure risks.

On the end-use side, the expanding global pharmaceutical pipeline, especially in oncology and CNS drugs, is increasing the volume of compounds requiring hERG liability testing. The rise of personalized medicine and targeted therapies further necessitates precise cardiotoxicity screening. Regulatory frameworks like ICH S7B and the CiPA initiative continue to emphasize hERG as a primary biomarker of cardiac safety, ensuring that it remains integral to preclinical workflows. As safety standards and development timelines grow increasingly stringent, hERG screening is becoming indispensable in de-risking and accelerating new drug development.

SCOPE OF STUDY

The report analyzes the hERG Screening market by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Gene KCNH2 Type, Mutant KCNH2 Type); Ion Channel (Voltage-Gated Ion Channel, Ligand-Gated Ion Channel); Application (Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application, Other Applications).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

ApconiX Ltd.; Aurigene Pharmaceutical Services; Charles River Laboratories; Creative Bioarray; Cyprotex (Evotec); Eurofins Discovery; Evotec SE; Mediford; Metrion Biosciences; Molecular Devices; Reaction Biology Corporation; Thermo Fisher Scientific; WuXi AppTec; Eurofins Discovery; Charles River Laboratories; ApconiX Ltd.; Creative Bioarray; Cyprotex (Evotec); Mediford; Metrion Biosciences

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

World Market Trajectories

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

hERG Screening – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 33 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Regulatory Scrutiny of Cardiac Safety Profiles Drives Demand for Robust hERG Screening Assays

FDA and ICH Guidelines Mandating QT Prolongation Risk Assessment Propel hERG Screening Integration

Early Toxicology Prioritization in Drug Discovery Enhances Market Demand for High-Throughput hERG Assays

Growth of Predictive Cardiotoxicity Platforms Fuels Innovation in Automated and AI-Powered hERG Screening

Expansion of Preclinical Outsourcing and CRO Services Boosts Global Accessibility of hERG Testing Capabilities

Advancements in In Vitro Ion Channel Electrophysiology Technologies Strengthen Assay Precision

Surging Small Molecule and Biologics Pipelines Accelerate Use of hERG Screening in Risk Evaluation

Demand for Integrated ADMET Profiling Solutions Spurs Bundling of hERG Screening With Other Safety Assays

hERG Patch Clamp and Automated Electrophysiology Systems Drive Adoption in Pharma R&D Labs

Increased Focus on Data-Driven Drug Design Strengthens Use of hERG Assays in Early Compound Screening

Rising Concern Over Drug Withdrawals and Black Box Warnings Underscores Importance of Proactive hERG Testing

Expansion of Stem Cell-Derived Cardiomyocyte Models Improves Physiological Relevance in hERG Assays

Development of Label-Free Technologies and Optical Assays Enhances Scalability of hERG Screening

4. GLOBAL MARKET PERSPECTIVE

World hERG Screening Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for hERG Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for hERG Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for hERG Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Gene KCNH2 Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Gene KCNH2 Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Gene KCNH2 Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Mutant KCNH2 Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Mutant KCNH2 Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Mutant KCNH2 Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Voltage-Gated Ion Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Voltage-Gated Ion Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Voltage-Gated Ion Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Ligand-Gated Ion Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Ligand-Gated Ion Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Ligand-Gated Ion Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Antiarrhythmic Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Antiarrhythmic Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Antiarrhythmic Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Antipsychotic Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Antipsychotic Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Antipsychotic Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Antibiotics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Antibiotics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Antibiotics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

JAPAN

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

CHINA

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

EUROPE

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for hERG Screening by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe Historic Review for hERG Screening by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for hERG Screening by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

FRANCE

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

GERMANY

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

UNITED KINGDOM

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

ASIA-PACIFIC

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for hERG Screening by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for hERG Screening by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for hERG Screening by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

AUSTRALIA

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

INDIA

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

LATIN AMERICA

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for hERG Screening by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Latin America Historic Review for hERG Screening by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for hERG Screening by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

MIDDLE EAST

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for hERG Screening by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Middle East Historic Review for hERG Screening by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for hERG Screening by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

AFRICA

hERG Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for hERG Screening by Type - Gene KCNH2 Type and Mutant KCNH2 Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for hERG Screening by Type - Percentage Breakdown of Value Sales for Gene KCNH2 Type and Mutant KCNH2 Type for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for hERG Screening by Ion Channel - Voltage-Gated Ion Channel and Ligand-Gated Ion Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for hERG Screening by Ion Channel - Percentage Breakdown of Value Sales for Voltage-Gated Ion Channel and Ligand-Gated Ion Channel for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for hERG Screening by Application - Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for hERG Screening by Application - Percentage Breakdown of Value Sales for Antiarrhythmic Application, Antipsychotic Application, Antibiotics Application and Other Applications for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll